Cargando…

Autologous bone marrow mononuclear cells as neuroprotective treatment of amyotrophic lateral sclerosis

Detalles Bibliográficos
Autores principales:	Ruiz-López, Francisco José, Blanquer, Miguel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870910/ https://www.ncbi.nlm.nih.gov/pubmed/27212914 http://dx.doi.org/10.4103/1673-5374.180730

Ejemplares similares

Glaucoma and amyotrophic lateral sclerosis, two kindred diseases?
por: Carreras, Francisco Javier
Publicado: (2016)

Dermic-derived fibroblasts for the study of amyotrophic lateral sclerosis
por: Riancho, Javier, et al.
Publicado: (2020)

Intramuscular Injection of Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis Patients: A Randomized Clinical Trial
por: Geijo-Barrientos, Emilio, et al.
Publicado: (2020)

Glucose metabolism in amyotrophic lateral sclerosis: it is bitter-sweet
por: Lerskiatiphanich, Titaya, et al.
Publicado: (2022)

Fibrosis as a common trait in amyotrophic lateral sclerosis tissues
por: Apolloni, Savina, et al.
Publicado: (2021)

Complement: a global immunometabolic regulator in amyotrophic lateral sclerosis
por: Lo, Martin W., et al.
Publicado: (2020)

P2X7 receptor antagonism in amyotrophic lateral sclerosis
por: Sluyter, Ronald, et al.
Publicado: (2017)

Amyotrophic lateral sclerosis disease burden: doing better at getting better
por: Volonté, Cinzia, et al.
Publicado: (2022)

The Efficacy and Safety of Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis: A Pilot Study
por: Shamsaei, Gholamreza, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis disease modifying therapeutics: a cell biological perspective
por: Tang, Bor Luen
Publicado: (2017)

Amyotrophic lateral sclerosis, a neurodegenerative motor neuron disease with retinal involvement
por: Ramírez, Ana I., et al.
Publicado: (2021)

Phenotypic heterogeneity in amyotrophic lateral sclerosis type 8 and modifying mechanisms of neurodegeneration
por: Oliveira, Danyllo, et al.
Publicado: (2021)

Neuroprotective Effect of Bexarotene in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis
por: Riancho, Javier, et al.
Publicado: (2015)

Amyotrophic Lateral Sclerosis Multiprotein Biomarkers in Peripheral Blood Mononuclear Cells
por: Nardo, Giovanni, et al.
Publicado: (2011)

Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis
por: Siwek, Tomasz, et al.
Publicado: (2020)

State-of-art modelling of inflammatory astrocyte-synapse interactions in injury and amyotrophic lateral sclerosis
por: Lakatos, András
Publicado: (2017)

Novel small molecule TRVA242 targets neuromuscular junction in amyotrophic lateral sclerosis
por: Bose, Poulomee
Publicado: (2019)

The important functional role of TDP-43 plays in amyotrophic lateral sclerosis-frontotemporal dementia
por: Chen, Liam
Publicado: (2020)

Mending the broken in amyotrophic lateral sclerosis: DNA damage and repair in motor neuron degeneration
por: Kim, Byung Woo, et al.
Publicado: (2020)

Ubiquitin homeostasis disruption, a common cause of proteostasis collapse in amyotrophic lateral sclerosis?
por: Chisholm, Christen G., et al.
Publicado: (2022)

Transplantation of autologous peripheral blood mononuclear cells in the subarachnoid space for amyotrophic lateral sclerosis: a safety analysis of 14 patients
por: Li, Xiao-yan, et al.
Publicado: (2017)

Mechanisms of Neuroprotection by Protein Disulphide Isomerase in Amyotrophic Lateral Sclerosis
por: Walker, Adam K., et al.
Publicado: (2011)

The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis
por: Tanaka, Hirotaka, et al.
Publicado: (2012)

Understanding metabolic flexibility: a potential key to unlocking metabolic therapies in amyotrophic lateral sclerosis?
por: Allen, Scott P.
Publicado: (2020)

Degenerative and regenerative processes in amyotrophic lateral sclerosis: motor reserve, adaptation and putative compensatory changes
por: Bede, Peter, et al.
Publicado: (2020)

Adipose-derived stem cell conditioned medium for the treatment of amyotrophic lateral sclerosis: pre-clinical evidence and potential for clinical application
por: Walker, Chandler L.
Publicado: (2019)

Chemically oligomerizable TDP-43: a novel chemogenetic tool for studying the pathophysiology of amyotrophic lateral sclerosis
por: Kanekura, Kohsuke, et al.
Publicado: (2022)

Novel Neuroprotective Multicomponent Therapy for Amyotrophic Lateral Sclerosis Designed by Networked Systems
por: Herrando-Grabulosa, Mireia, et al.
Publicado: (2016)

Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?
por: Moreau, Caroline, et al.
Publicado: (2018)

Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis
por: Muzio, Luca, et al.
Publicado: (2020)

Neuroprotective effects of violacein in a model of inherited amyotrophic lateral sclerosis
por: Olivera-Bravo, Silvia, et al.
Publicado: (2022)

The neuroprotective effects of human growth hormone as a potential treatment for amyotrophic lateral sclerosis
por: Chung, Jin-Young, et al.
Publicado: (2015)

Clinical improvement after autologous bone marrow mononuclear cell transplantation
por: Dohmann, HF, et al.
Publicado: (2003)

Autologous Bone Marrow Mononuclear Cells Intrathecal Transplantation in Chronic Stroke
por: Sharma, Alok, et al.
Publicado: (2014)

Poor Bone Quality in Patients With Amyotrophic Lateral Sclerosis
por: Caplliure-Llopis, Jordi, et al.
Publicado: (2020)

Combination of novel RNA sequencing and sophisticated network modeling to reveal a common denominator in amyotrophic lateral sclerosis?
por: Dash, Banaja P., et al.
Publicado: (2023)

Biomarkers in Human Peripheral Blood Mononuclear Cells: The State of the Art in Amyotrophic Lateral Sclerosis
por: Pansarasa, Orietta, et al.
Publicado: (2022)

NAD(+) Precursors and Antioxidants for the Treatment of Amyotrophic Lateral Sclerosis
por: Obrador, Elena, et al.
Publicado: (2021)

Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection
por: Cha, Sun Joo, et al.
Publicado: (2022)

Prospects for bone marrow cell therapy in amyotrophic lateral sclerosis: how far are we from a clinical treatment?
por: Gubert, Fernanda, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_osaak0bsa7f7k99iru6s020lcm